Browsing Category
Pharma Industry News
4729 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Zelira Therapeutics (ASX:ZLD) secures $33m to advance HOPE 1 autism therapy through U.S. FDA trials
Find out how Zelira’s US$33M SPV deal with ThirdGate Capital is reshaping its FDA strategy for HOPE 1 and shaking up the autism biotech space.
Sun Pharmaceutical (NSE: SUNPHARMA) launches UNLOXCYT in U.S. for aCSCC
Sun Pharma's UNLOXCYT is now available in the U.S. for advanced CSCC. Find out how this checkpoint inhibitor could reshape skin cancer treatment today.
Is pelareorep gaining traction? Oncolytics Biotech’s updated GOBLET data draws investor focus to third-line anal cancer
Find out why Oncolytics Biotech’s updated GOBLET cohort 4 data is drawing investor attention to pelareorep’s role in third-line anal cancer.
How elraglusib’s long-term Phase 2 survival data positions Actuate Therapeutics in a difficult pancreatic cancer market
Find out how elraglusib’s long-term Phase 2 survival data is positioning Actuate Therapeutics in the challenging metastatic pancreatic cancer market.
Is a C$16m LIFE offering from ZYUS Life Sciences the catalyst investors are watching in cannabinoid pharma?
ZYUS Life Sciences launches a C$15–16 million LIFE offering to accelerate clinical execution and regulatory readiness. Find out what it means for investors.
ImmunityBio (NASDAQ: IBRX) secures Saudi FDA approval for ANKTIVA in BCG-unresponsive bladder cancer
ImmunityBio secures Saudi approval for ANKTIVA in NMIBC. Find out how this reshapes the company’s MENA strategy and immunotherapy ambitions.
No fridge, no problem: Stablepharma and AFT join forces to make critical drugs shelf-stable
Stablepharma and AFT team up to develop fridge-free cancer and infection drugs. Find out how this could reshape pharma logistics and global access.
Abbisko Therapeutics’ pimicotinib clears FDA filing hurdle: Why this matters for rare tumor strategy and global biotech credibility
Abbisko Therapeutics clears a key FDA hurdle for pimicotinib. Find out why this TGCT filing could reshape rare tumor strategy and global biotech credibility.
UK fast-tracks clinical trials with 14-day reviews and AI simulation support to regain R&D edge
Find out how MHRA’s 2026 trial reforms—fast-track routes, AI models, and 14-day reviews—aim to make the UK a global leader in clinical research again.
Syntheia signs LOI to acquire SATCO, targeting lab data integration in pharma R&D workflows
Syntheia signs LOI to acquire SATCO and expand its pharma R&D data stack. Explore how this deal could reshape structured content workflows for life sciences.